Results 111 to 120 of about 590,194 (288)

Adult Vaccine Coadministration Is Safe, Effective, and Acceptable: Results of a Survey of the Literature

Influenza and Other Respiratory Viruses, Volume 19, Issue 3, March 2025.
ABSTRACT Background Coadministration of vaccines in children is a long‐standing practice that has proven to be safe and effective in improving the efficiency of vaccine administration, thereby increasing immunization coverage rates. As the number of vaccines routinely recommended for adults increases, and with limited opportunities for adults to have ...
Litjen Tan, Dana Trevas, Ann R. Falsey
wiley   +1 more source

Trends and variations in the epidemiology of meningococcal disease in Kuwait 1987–2013

Journal of Infection and Public Health, 2015
Summary: The introduction of Haemophilus influenzae type b (Hib) conjugate vaccine and conjugate pneumococcal vaccine into routine childhood vaccination in Kuwait has resulted in the emergence of Neisseria meningitidis as the leading cause of invasive ...
Entesar H. Husain, Mohammad Barakat, Mosaab Al-Saleh   +2 more
doaj  

A Case of Atypical Hemolytic Uremic Syndrome With a Complement Factor I Mutation Triggered by a Femoral Neck Fracture

Nephrology, Volume 30, Issue 3, March 2025.
ABSTRACT Atypical hemolytic uremic syndrome is a thrombotic microangiopathy caused by the abnormal activation of the alternative complement pathway. Mutations in complement‐related genes and autoantibodies against complement regulators are involved in the pathogenesis of this condition; the frequency of, and prognosis of patients harbouring, each ...
Toshiki Kano, Hiroaki Io, Yu Sasaki, Masahiro Muto, Sayaka Muto, Kei Ogiwara, Arisa Ikeda, Hiroyuki Iwasaki, Yusuke Suzuki   +8 more
wiley   +1 more source

Meningococcal Group B Vaccine For The Prevention Of Invasive Meningococcal Disease Caused By Neisseria meningitidis Serogroup B

Infection and Drug Resistance, 2019
Invasive meningococcal disease (IMD) is a major public health concern because of its high case fatality, long-term morbidity, and potential to course with outbreaks.
I. Rivero-Calle, P. F. Raguindin, J. Gómez-Rial, C. Rodríguez-Tenreiro, F. Martinón-Torres   +4 more
semanticscholar   +1 more source

Oropharyngeal Adverse Events to Drugs and Vaccines: Pharmacovigilance Data From Italy (2019–2021)

Oral Diseases, Volume 31, Issue 3, Page 993-1005, March 2025.
ABSTRACT Objectives The aim of this study was to perform a descriptive analysis of oropharyngeal adverse events (AEs) related to drugs and/or vaccines in order to provide useful information for clinicians. Methods Data related to three regions of Italy were analyzed from 2019 to 2021 by using the National Pharmacovigilance database.
Liberata Sportiello, Gaetano La Mantia, Vera Panzarella, Giuseppe Colella, Simona Potenza, Giacomo Oteri, Laura Sottosanti, Giuseppe Bellavia, Mario Gaio, Alessia Zinzi, Ilaria Morreale, Gaspare Parrinello, Elisabetta Geninatti, Eleonora Marrazzo, Vittorio Fusco, Annalisa Capuano, Giuseppina Campisi   +16 more
wiley   +1 more source

Progress toward the global control of Neisseria meningitidis: 21st century vaccines, current guidelines, and challenges for future vaccine development

Human Vaccines & Immunotherapeutics, 2018
The control of meningitis, meningococcemia and other infections caused by Neisseria meningitidis is a significant global health challenge. Substantial progress has occurred in the last twenty years in meningococcal vaccine development and global ...
A. W. Dretler, N. G. Rouphael, D. S. Stephens   +2 more
doaj   +1 more source

Meningococcal Vaccines: Current Status and Emerging Strategies

Vaccines, 2018
Neisseria meningitidis causes most cases of bacterial meningitis. Meningococcal meningitis is a public health burden to both developed and developing countries throughout the world.
Pumtiwitt C. McCarthy, Abeer Sharyan, Laleh Sheikhi Moghaddam   +2 more
doaj   +1 more source

Meningococcal B vaccine (4CMenB): the journey from research to real world experience

Expert Review of Vaccines, 2018
Introduction: Neisseria meningitidis serogroup B (MenB) is the most common cause of bacterial meningitis in many industrialized countries and occurs at any age. The highest incidence is in infants aged
R. Rappuoli, M. Pizza, V. Masignani, K. Vadivelu   +3 more
semanticscholar   +1 more source

Using the tetravalent meningococcal polysaccharide-protein conjugate vaccine in the prevention of meningococcal disease

Therapeutics and Clinical Risk Management, 2008
Sanford R KimmelUniversity of Toledo College of Medicine, Department of Family Medicine, Toledo, OH, USAAbstract: Invasive meningococcal disease occurs worldwide causing an estimated 50,000–135,000 deaths each year in addition to significant ...
Sanford R Kimmel
doaj  

Public policy for meningococcal vaccination [PDF]

Human Vaccines & Immunotherapeutics, 2018
On an individual basis, meningococcal disease is consistently shown to be one of the most feared potential childhood infections. On a population level, any clustering of cases or increase in disease requires proactive health protection management, while epidemics can be devastating.
openaire   +3 more sources